Endurant Capital Management’s Terns Pharmaceuticals TERN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-135,994	Closed	-$1.38M	–	64
2022 Q4	$1.38M	Buy	+135,994	New	+$1.38M	0.56%	32